Reviewed how genetic variants and alternative splicing contribute to prostate cancer development, highlighting mechanisms beyond traditional gene expression analysis.
Investigated the potential regulatory interaction between hsa-miR-31-5p and DICER1 in penile squamous cell carcinoma (PSCC) using an in silico bioinformatics approach.
A systematic review and meta-analysis of 19,304 patients examining alternative splicing alterations and therapy resistance in metastatic castration-resistant prostate cancer (mCRPC).
03 / Approach
Across disciplines. Toward better questions.
My academic background brings together medicine and Information Systems. My research interests include molecular oncology, microRNA regulation, genetic variation, alternative splicing, and computational approaches to disease.